Abstract
Introduction
In most of the rodent species, as trophoblasts begin to attach to the receptive uterine epithelium during implantation, the uterus clamps around the blastocyst. Thereafter, the following remarkable events take place sequentially: transepithelial invasion of trophoblasts, transformation of uterine stroma, recruitment of inflammatory and endothelial cells into the endometrium and apoptosis of uterine epithelial cells. Thus, implantation is a highly coordinated process in which specialized cells of the outer layer of the embryo, the trophoblasts, establish contacts with highly sensitized luminal epithelial cells. Coordination between the two alien types of cells involves regulatory production of proteolytic enzymes, growth factors, cytokines and hormones. Additionally, the cell surface components also become functionally available to support attachment of trophoblasts and uterine cells.
Later acquisitions in the embryo and the uterus include differentiation and ordered activation of gene expression, programmed changes of mRNA and protein of the uterine cells as well as the expression of extracellular matrix (ECM) receptors and matrix-degrading activities in the trophoblasts that augment their invasion through the endometrium [1] . In addition to these activities, extensive changes occur in the endometrial vascular architecture, resulting in increased blood flow at the site of preplacental development [1] .
The trophoblasts contain a large number of secondary lysosomes and phagosomes, which exhibit strong phagocytic activity. This activity includes engulfment not only of necrosing endometrial epithelial and stromal cells but also cells of lymphopoietic origin [2] [3] [4] . As the phagocytic activity of trophoblasts is a continuous process, it leads to the formation of large sinuses in the mesometrial region in which the maternal blood flows for the nourishment of the developing placenta and the embryo. Whether the unrestricted flow is due to inhibition of platelet aggregation caused by the proliferating trophoblasts or the differentiated endometrial stromal cells is not known.
Earlier studies assumed that pre-and peri-implantation embryos released platelet-activating factor (PAF) [5] . Many other cells including neutrophils, monocytes, macrophages, endothelial and smooth muscle cells also produce PAF. Therefore the release of PAF is not necessarily a specific action of only pre-and peri-implantation embryos [6] . Moreover, PAF is also known to act as an autocoid. Further, significant thrombocytopenia is also reported to occur during pre-and peri-implantation phase of embryonic development [7] . The phenomenon is augmented in the presence of a zygote since the injection of the conditioned media that contained a chemical signal homologous to PAF has been found to promote this phenomenon [8] . However, the direct involvement of PAF in platelet aggregation (promotion or inhibition) has not been supported by more recent studies [9] .
In another study, O'Neill [10] showed that trophoblasts proliferated more in the presence of plateletderived growth factor (PDGF) and were dependent on the platelet count as this phenomenon was observed only in platelet-rich plasma (PRP). Whether or not the PDGFinduced trophoblast outgrowth can be linked with platelet aggregation phenomena is difficult to say at present. Since no information is available in the literature on platelet aggregation, the present study was carried out to examine the effect of trophoplast and stromal cells on the aggregation of platelets.
Materials and Methods

Trophoblasts
Adult Sprague-Dawley female rats (150-200 g) from the Central Drug Research Institute, Lucknow, India, were used. Virgin females at proestrus were mated with males (in 2:1 ratio) overnight in a plastic cage. Vaginal smears were examined the following morning for confirmation of mating. This day was considered as day 1 postcoitum (p.c.). Sperm-positive animals were sacrificed on day 12 p.c. and the uterine horns containing implantations were excised and placed in Hanks' balanced salt solution (HBSS).
From each implant the decidual swellings were taken out after removing serosa and myometrial coverings (by cutting the entire horn longitudinally) and floated in buffer. Each swelling was cut sagittally into two halves by a sharp-edged scalpel. The embryo (lying in one half) was scrapped carefully with a needle, washed in buffer, and then transferred to a glass cuvette (15 mm in diameter) containing HBSS, using a glass microcapillary attached to a hand-operated micromanipulator (Assistent Micro-Pipex, No. 558, Lapine Scientific Co., Germany). The embryo has a red cap-like structure (visible under the stereo binocular), very rich in trophoblasts, designated as the ectoplacental cone (EPC). The EPCs were separated by sharply pointed microneedles and then teased into minute fragments, processed for isolation of trophoblast cells according to a method described earlier [11] . Finally, the pellet containing the homogeneous colony of trophoblasts was suspended in 0.5 ml Dulbecco's Modified Eagle's Medium (DMEM). Prior to reacting with PRP, the number of cells was counted in a hemocytometer. Cell viability was checked by the trypan blue dye exclusion method [12] and only when the number of viable cells exceeded 90% were then used for the study.
Isolated trophoblasts were transferred to a tube containing 1% paraformaldehyde solution and kept for 10 min. After fixation, the cell suspension was centrifuged, and the resultant pellet containing fixed cells was suspended in HBSS.
Decidual Cells
The remaining halves of the swellings (after removing the egg cylinder) were washed in fresh culture medium (M-199) and then minced into minute pieces (0.1 mm 2 ). These pieces were exposed to collagenase (5.0 mg in 3.0 ml medium) in a 10.0-ml conical flask placed on a Dubnoff metabolic shaker (37°C) to isolate decidual cells according to a method described earlier [13] . Cell viability was assessed and total cell counts were performed on a hemocytometer. The total cell count was 3.86 ! 10 6 /ml. All the biochemicals were procured from Sigma, St. Louis, USA.
Platelet-Rich Plasma
Blood was collected by cardiac puncture from male SpragueDawley rats (135-150 g), anaesthetized with ether (hydroquinone, 0.00018% w/v, TKM Pharma, Hyderabad, India) and placed into sodium citrate (3.8% w/v, 9:1 v/v)-pretreated tubes. The citrated blood was centrifuged at 180 g for 20 min (at 20°C) to separate PRP.
Platelet Aggregation
The PRP (400 Ìl, 1 ! 10 8 cells) was preincubated with the trophoblast cell suspensions (1 ! 10 4 -1 ! 10 6 ) in a volume of 100 Ìl buffer or the suspension media (DMEM or HBSS) at 37°C for 3-5 min. Platelet aggregation was induced by adenosine 5)-diphosphate (ADP; 2.0-6.5 ÌM ) and monitored in a dual-channel aggregometer (model 560; Chronolog Corporation, Havertown, Pa., USA) with Tewari/Singh/Farheen/Dikshit/Mehrotra continuous stirring at 700 rpm [14] . The data were recorded on a chart recorder (Model 707, Chronolog Corporation). The difference in light transmission between PRP and the suspension media was designated as 100% and was used to calculate the percent aggregation. The live trophoblast cell suspension at various concentrations, the live decidual cell suspension (3.86 ! 10 6 ), and the fixed trophoblast cell suspensions (2 ! 10 4 -10 5 ) were added to either PRP or the suspension media and the platelet aggregation response was monitored.
Statistical significance was determined by using ANOVA and Student's t test. Values reported are means B SE. The difference between the two groups was considered significant at p ! 0.01.
Analysis of Trophoblast-Cell-Conditioned Media
The trophoblast cells, in the concentrations at which they inhibited platelet aggregation, were seeded in a round culture dish (35 mm; Nunc, Denmark) containing DMEM complemented with 10% FCS. The dish was placed in a humidified CO 2 incubator (Forma Scientific Co., USA). After 24 h, when the cells settled and began to grow, the complemented medium was replaced by medium without complement. The culture was continued for 48 h after which complete confluency was observed. The conditioned medium was collected in a tube and ultracentrifuged to remove debris and/or any contaminants. The medium was then extensively dialysed to remove interfering salts and stored in lyophilized form at -20°C before analysis by single-dimension gel electrophoresis. The protein content in the reconstituted pellet of the conditioned medium was estimated according to Bradford [15] .
Results
The ADP (2.0-6.5 ÌM)-induced platelet aggregation in the presence of medium without trophoblast cells was 78 B 2% ( fig. 1 ). The addition of two different concentrations of trophoblasts (5 ! 10 4 , and 7 ! 10 4 cells) to the PRP did not produce any change (vs. control, p 1 0.05), but decreased the ADP-induced platelet aggregation response to 69 B 1% and 60 B 3%, respectively (vs. control, p ! 0.01) (table 1). However, when the trophoblast cell number was increased to 1-2 ! 10 5 , the cell suspension itself produced a platelet aggregation response (57 B 7%) even in the absence of ADP. The addition of 2 ! 10 4 trophoblast cells to PRP, however, had no effect on ADPinduced platelet aggregation. Fixed trophoblast cells (2 ! 10 4 -2 ! 10 5 cells) also had no effect on ADP-induced aggregation response. Similarly, the endometrial stromal (decidual) cells of corresponding gestational age did not have any effect on the aggregation response.
The analysis of trophoblast-cell-conditioned media (5-7 ! 10 4 concentrations) on gel electrophoresis revealed a major protein band at 68 kD and a minor one at approximately 60 kD. These bands were, however, absent when the medium conditioned with 1-2 ! 10 4 cell concentra- tions was loaded on the gel ( fig. 2 ). The media conditioned with trophoblasts at 5-7 ! 10 4 cell numbers also failed to produce any inhibitory response (as compared to the trophoblasts at these cell numbers in suspension).
Discussion
Results of the present study reveal that the rat trophoblasts did not affect ADP-induced platelet aggregation at a lower cell number (2 ! 10 4 ), but inhibited aggregation significantly (p ! 0.01) when used at slightly higher cell numbers (between 5 ! 10 4 and 7 ! 10 4 cells) suspended in medium or buffer. However, cell numbers above 7 ! 10 4 and up to 1-2 ! 10 5 did not show any inhibitory response. Rather, a proaggregatory response (even in the absence of ADP) was noticed.
The results, though enigmatic, are quite interesting. On the one had, a low range of cell concentrations showed an inhibitory response, whereas a higher range of cell concentrations did not. One explanation for these results is that during early embryonic development and placental morphogenesis, the trophoblast cells encroach upon the space left by phagocytosis of endometrial cells in the mesometrial region. Once the placenta is formed and the embryo is fully anchored, the invading process is checked by the cells of differentiated endometrium known as decidua. The trophoblasts may then go into a resting stage, where probably no further proliferation takes place. Thus, when the numbers of trophoblasts are moderate (5-7 ! 10 4 ), as observed in this study, the cells are in a proliferating state, necessitating an uninterrupted flow of blood. However, once the placenta is established, and the number of cells increased (1-2 ! 10 5 ), the possibility of platelet aggregation increases, enabling the pregnancy to be fully sustained.
The above explanation is consistent with reports showing that during early gestation, when the number of trophoblast cells are low and the level of adenosine is high, there is less platelet aggregation [16, 17] . However, during late gestation, when the numbers of trophoblast cells are very high, the adenosine level becomes very low due to the elevation of the enzyme adenosine deaminase [18] . Consequently, the inhibitory response of adenosine is decreased and the proaggregatory response occurs due to the absence of adenosine.
The decidual cell suspension, on the contrary, did not show any effect on aggregation, indicating that the inhibition of platelet aggregation during early pregnancy was caused by trophoblast cells only.
On analysis of day 12 trophoblast-conditioned medium, a 68-kD protein was isolated which, we assumed, might be mediating inhibition or stimulation of platelet aggregation depending on the number of cells, vis-à-vis the concentration of the protein. We speculated that this protein was believed to be synthesized intracellulary because there was no response in the medium containing fixed trophoblast cells (table 1) . However, since we did not observe any change in platelet aggregation by the trophoblast-conditioned medium, the protein appears not to Tewari/Singh/Farheen/Dikshit/Mehrotra be secretory but labile and is released after cell-to-cell interaction of trophoblasts and platelets. This protein does not appear to be related to PAF because PAF is reported to induce thrombocytopenia during the pre-and peri-implantation phases of pregnancy [8] .
From these findings, it may thus be inferred that midgestation rat trophoblasts secrete some substance which inhibits platelet aggregation. The inhibitory response is, however, dependent on cell density. This is the first in vitro study to our knowledge reporting the presence or appearance of PAF in the trophoblasts during invasion of the endometrium in early pregnancy. However, the nature of this factor is yet to be established. In vitro studies are, however, not a replica of events in vivo.
Conclusion
On day 12 of gestation of a rat embryo, the inhibition response to platelet aggregation was cell specific and concentration dependent. A 68-kD protein was detected in a trophoblast-conditioned medium at concentrations of 5-7 ! 10 4 cells but not at 1-2 ! 10 5 cells. The inhibitory or stimulatory effect of platelet aggregation does not seem to be dependent on the presence of this protein.
